Table 1: Methods for compliance in special patient groups and with specific health problems.
Methods for compliance |
Special patient groups with specific health problems
|
|||||||||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
|
Rapport and continuity of care |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
Confidentiality |
|
|
|
|
X |
|
X |
|
X |
|
|
|
X |
|
Prevention of effects of ADRs on compliance |
|
X |
|
X |
X |
|
|
|
X |
|
X |
X |
|
|
Simplify the therapeutic regimen |
|
X |
|
X |
|
|
|
|
|
X |
X |
X |
|
|
Self-monitoring |
|
X |
|
X |
|
|
|
|
|
X |
|
|
|
|
Avoid giving the impression that the drug replaces the need for changes in habits |
|
X |
X |
X |
|
|
|
|
|
X |
X |
|
|
|
Know the patient's agenda, the perceptions of the disease, and the importance and their confidence |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
X |
Involve the patient in the decision |
|
X |
X |
X |
|
|
|
|
|
X |
|
|
|
|
Motivational interview and negotiation |
|
|
|
|
|
|
|
|
X |
|
|
|
X |
|
1: Cardiovascular risk factors (hypercholesterolemia, hypertension, etc.) and coronary heart disease (CHD); 2: Hypertension; 3: Hyperlipidemia; 4: Diabetes mellitus; 5: HIV; 6: Osteomuscular diseases; 7: Contraception; 8: Gastroenterological diseases; 9: Psychiatric diseases; 10: Bronchial asthma and chronic obstructive pulmonary disease; 11:Kidney diseases; 12: Elders; 13: Teenagers; 14: Disabled people.